Guangzheng Eye Hospital Group Co., Ltd.
Simbolis: 002524.SZ
SHZ
4.09
CNYRinkos kaina šiandien
-1223.9654
P/E santykis
0.0000
PEG koeficientas
1.99B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 307.1 | 91.1 | 65.4 | 89.3 | |||||||||||||||||
balance-sheet.row.short-term-investments | -143.74 | 0 | -68 | 31 | |||||||||||||||||
balance-sheet.row.net-receivables | 782.74 | 190.2 | 143.5 | 192.1 | |||||||||||||||||
balance-sheet.row.inventory | 151.98 | 29.6 | 57.3 | 53.2 | |||||||||||||||||
balance-sheet.row.other-current-assets | 23.34 | 5.6 | 3.3 | 5.9 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1265.15 | 316.5 | 269.5 | 340.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2511.93 | 619.7 | 687.6 | 744.2 | |||||||||||||||||
balance-sheet.row.goodwill | 1511.56 | 377.3 | 378.5 | 517.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 159.62 | 40 | 37 | 55.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1671.19 | 417.2 | 415.5 | 572.8 | |||||||||||||||||
balance-sheet.row.long-term-investments | 181.47 | 0 | 94 | 7.2 | |||||||||||||||||
balance-sheet.row.tax-assets | 182.98 | 49.7 | 40.6 | 40.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 376.81 | 146.3 | 50.2 | 123.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 4924.38 | 1232.9 | 1288 | 1488.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.account-payables | 1052.98 | 261.3 | 275.5 | 262.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 1503.14 | 383.2 | 360.8 | 289 | |||||||||||||||||
balance-sheet.row.tax-payables | 63.8 | 16 | 10.9 | 15.2 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2004.97 | 493.8 | 448.9 | 505.7 | |||||||||||||||||
Deferred Revenue Non Current | 13.05 | 0 | 0 | 30 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.33 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29.31 | 7.7 | 107.5 | 10.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2047.9 | 507.6 | 468.6 | 507.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1693.54 | 417.3 | 448.4 | 475.7 | |||||||||||||||||
balance-sheet.row.total-liab | 5054.77 | 1263.5 | 1282.7 | 1487.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 2068.45 | 518 | 515.4 | 516.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1219.92 | -299.7 | -308.4 | -214.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 200.82 | 0 | 46.5 | 16.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.22 | 65 | 19.6 | 21.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1123.57 | 283.3 | 273.1 | 340.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6189.53 | 1549.4 | 1557.5 | 1828.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 11.18 | 2.6 | 1.7 | 0.8 | |||||||||||||||||
balance-sheet.row.total-equity | 1134.75 | 285.9 | 274.8 | 341.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6189.53 | - | - | - | |||||||||||||||||
Total Investments | 75.6 | 19.1 | 26 | 38.2 | |||||||||||||||||
balance-sheet.row.total-debt | 3508.11 | 877 | 809.7 | 794.7 | |||||||||||||||||
balance-sheet.row.net-debt | 3201.01 | 785.9 | 744.3 | 736.4 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 18.29 | -77.8 | 36.4 | 32.1 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -23.36 | 100 | 106.4 | 62.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | -3.08 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0.15 | 2.5 | 6 | 13.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -108.9 | 27.9 | 32.8 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 48.7 | -23.6 | 28.8 | ||||||||||||||||
cash-flows.row.inventory | 0 | -8.7 | 16.9 | -3.9 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.7 | 35.8 | 18.8 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.2 | -1.2 | -10.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 39.32 | 210.7 | -30.1 | 25.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 31.18 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 25.73 | 1.8 | 83.9 | 194.5 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -25.73 | -116.4 | -262.1 | -543 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4.07 | 54.7 | 228.4 | 33.9 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.92 | 0 | 3.5 | 7.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -6.23 | -100.6 | 1.2 | -369.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -170.2 | -232 | -467 | -130.7 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.1 | 22.7 | 29.5 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.1 | -22.7 | -29.5 | ||||||||||||||||
cash-flows.row.dividends-paid | -15.3 | -11.9 | -16.5 | -46.6 | ||||||||||||||||
cash-flows.row.other-financing-activites | 68.2 | 232.2 | 273.7 | 255.3 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.06 | -11.8 | -209.8 | 78 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -3.24 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -29.13 | 12 | -63.2 | -136.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 255.13 | 57 | 45 | 108.3 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 284.26 | 45 | 108.3 | 244.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 31.18 | 124.3 | 145.4 | 155 | ||||||||||||||||
cash-flows.row.capital-expenditure | -21.71 | -40.7 | -52.5 | -62.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | 9.46 | 83.6 | 92.9 | 92.9 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1058.07 | 1074.9 | 767.4 | 1044.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 689.43 | 697.9 | 575.9 | 709.2 | |||||||||||||||||
income-statement-row.row.gross-profit | 368.64 | 377 | 191.5 | 335.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 5.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 37.86 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 337.23 | 328.7 | 281.5 | 334.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1026.66 | 1026.6 | 857.4 | 1043.5 | |||||||||||||||||
income-statement-row.row.interest-income | 0.76 | 0.7 | 0.8 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 191.47 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.04 | 0.9 | 104.7 | 89.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.04 | 0.9 | -174.2 | -32.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 39.08 | 38.8 | 36.3 | 37.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 40.76 | 100.3 | 100 | 106.4 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 35.43 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -5.32 | 7 | 98.6 | 77 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5.28 | 7.9 | -75.6 | 44.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -3.23 | -1.8 | 2.2 | 8.5 | |||||||||||||||||
income-statement-row.row.net-income | -1.62 | 9.3 | -77.8 | 36.9 |
Dažnai užduodami klausimai
Kas yra Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) bendras turtas?
Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) bendras turtas yra 1549365088.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 447607126.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.348.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.020.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.002.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.005.
Kas yra Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 9255045.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 877008780.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 328663038.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 65054312.000.